The application of CPAP devices is considered as a backbone for people who have sleep apnea. These devices keep airways open ...

Fears that GLP-1 obesity drugs would reduce demand for ResMed’s various CPAP airflow machines have proven unfounded..

ResMed (NYSE: RMD) today announced new patient-centric products designed to enhance therapy for sleep apnea patients.

NEW YORK — The morning after presenting an upbeat outlook to analysts in a gilded hall in the New York Stock Exchange building, Mick Farrell, the CEO of ResMed, looked refreshed, despite a post ...

Sleep apnoea devices giant ResMed has laid out an ambitious growth strategy aiming to broaden its product lines and notch up ...

Since its inception in 2009, Air Voel has been a pioneer in helping Canadians manage their sleep apnea effectively. As a leading online provider of CPAP supplies, Air Voel has established itself as a ...

ResMed (RMD) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...

ResMed makes it easier for people to manage their sleep health and stay on (continuous positive airway pressure) CPAP treatment by integrating its leading myAir™ consumer app with Apple and Android ...

Dawn Dawn myAir MyAir LUXE LUXE ResMed makes it easier for people to manage their sleep health and stay on (continuous ...

If you have sleep apnea, you may need a CPAP machine to allow you to breathe continuously while you sleep. Share on Pinterest A continuous positive airway pressure (CPAP) machine is the most ...

such as the AirTouch N30i next-generation CPAP mask unveiled earlier today. Capitalize on ResMed’s market opportunity and brand advantage in broader sleep health and breathing health adjacencies ...

Many analysts see GLP-1 drugs, which have shown positive results in treating sleep apnea, as a threat to CPAP companies. But ResMed, which makes sleep apnea devices, sees an opportunity.